# OncoVanta Therapeutics jobs and careers

> 0 open roles at OncoVanta Therapeutics as of October 23, 2026. Source: https://www.thejobsmap.com/company/oncovanta-therapeutics

OncoVanta Therapeutics is a biotechnology company pioneering next-generation immunotherapies targeting mutant p53, the most frequently altered gene in human cancers. More than 50% of all tumors harbor TP53 mutations, yet no approved therapies directly address this major unmet medical need. Leveraging NIH-derived TCR (T- cell receptor) assets and cutting edge cell therapy platforms, OncoVants is advancing a novel pipeline of TCR-based adoptive cell therapies designed to selectively target hotspot p53 mutations in solid tumors. Our Mission is clear; turn breakthrough science into life-saving medicines for patients with hard-to treat cancers. Specialties: • Adoptive Cell Therapy (ACT) • T Cell Receptor (TCR) Engineering • p53 Mutant Oncology • Immuno-Oncology (I/O) • Translational Research &; Development • Biotech Partnerships & Licensing

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Employees | 1 to 10 |
| Website | https://oncovanta.com |

## Leadership

- Roman Owens, Founder & Chief Executive Officer | OncoVanta Therapeutics, Inc

## Common questions

### Is OncoVanta Therapeutics hiring right now?

OncoVanta Therapeutics has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on OncoVanta Therapeutics's careers site.

### Who leads OncoVanta Therapeutics?

Roman Owens, Founder & Chief Executive Officer | OncoVanta Therapeutics, Inc, is at the top of OncoVanta Therapeutics's org chart.

### How do I apply for a job at OncoVanta Therapeutics?

Pick a role on OncoVanta Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on OncoVanta Therapeutics's own careers site, so you apply directly with the employer.